# Lymphoedema after breast cancer: risk reduction, surveillance, early compression and treatment

Source: https://onco.cc/protocols/lymphoedema-risk-reduction-surveillance-and-treatment/  
OnCo record `lymphoedema-risk-reduction-surveillance-and-treatment` (Protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

After surgery or radiotherapy to the armpit nodes, the arm can swell (lymphoedema). Measuring the arm before surgery and at check-ups can find swelling early, when a compression sleeve may stop it becoming permanent. Exercise, including weights, is safe. Infection raises the risk; the old bans on blood pressure, needles or flying are not well supported. Report arm swelling, heaviness or redness.

## Summary

MASCC 2024 (Delphi, 55 experts, statements based on randomised trials and systematic reviews): prioritise people with axillary node dissection, axillary radiotherapy, early relative arm volume increase, many nodes removed and BMI of 30 or more; run prospective surveillance where resources allow (93.8% agreement), with a pre-surgical baseline, starting within 3 months of surgery, every 3 to 4 months in year 1 then every 6 to 12 months for at least 24 months; bioimpedance spectroscopy (L-Dex rise of 6.5 or more) or a 5 to under 10% volume increase or any arm symptom triggers a compression sleeve for at least 4 to 6 weeks; 10% or more triggers more intensive treatment; prophylactic compression sleeves, axillary reverse mapping and prophylactic lymphatic reconstruction are options where expertise and resources allow.

The APTA interventions guideline (2020) recommends prospective surveillance in high-risk groups (Grade C): a preoperative measurement with bioimpedance spectroscopy or volume, then every 3 months for the first year and twice a year for up to 5 years. Subclinical (ISL stage 0) lymphoedema may be treated with education, self-massage and compression garments (Grade C), escalating to complete decongestive therapy (CDT) if it persists. For early (stage I) lymphoedema, an individually fitted compression garment, an exercise programme and education are first-line (Grade A); CDT is used for moderate and late lymphoedema (stages II and III, Grade B), followed by home care with self-massage, a fitted garment and exercise (Grade B). Supervised progressive resistance training from at least one month after surgery is safe (Grade A) and aerobic exercise should be provided (Grade A); therapist manual lymphatic drainage may not reduce risk (Grade C), and a fitted compression garment for high-risk patients with exercise may reduce it (Grade B). PAL (n=154): slowly progressive weight lifting did not increase lymphoedema.

In the PREVENT trial (963 randomised, 879 analysed), surveillance by bioimpedance spectroscopy triggered a four-week compression sleeve less often than tape measurement (20.1 against 27.5 per cent), and fewer of those treated progressed to chronic lymphoedema needing CDT (7.9 against 19.2 per cent, relative risk 0.41). New cases kept appearing in years two and three, so the authors advise monitoring for at least three years. The APTA diagnosis guideline (2017) set bioimpedance cut-offs of an L-Dex above 7.1 without a baseline or more than 10 above baseline (Grade B); its authors updated the bioimpedance advice in 2018, which was not read.

On the traditional precautions, in a 3,041-measurement cohort blood draws, injections, blood pressure readings and flights were not associated with arm volume increase, while cellulitis was a risk; a 2024 evidence map prepared for the American Cancer Society and Lymphology Association of North America summit found the evidence sufficient to refute many of the previously claimed risk factors, and called a 'just in case' approach to education possibly inappropriate.

## Fields

- Kind: Protocol
- Last checked: 2026-11-11
- Also known as: breast cancer-related lymphoedema; BCRL; BCRL prevention; breast cancer-related lymphoedema prevention; lymphedema risk reduction; lymphoedema precautions; prospective surveillance for lymphoedema; bioimpedance spectroscopy; L-Dex; arm precautions after lymph node surgery; arm care after axillary surgery; complete decongestive therapy
- Tags: protocol; lymphoedema; survivorship; breast-cancer

## Connected records

- protocols: [Exercise during and after cancer treatment: assessment, dose and referral](https://onco.cc/protocols/exercise-during-and-after-cancer-treatment/), [Follow-up after treatment for early breast cancer](https://onco.cc/protocols/breast-cancer-follow-up-after-treatment/), [Sentinel node tracers and blue dye: injection, allergic reaction readiness and aftercare](https://onco.cc/protocols/sentinel-node-tracers-and-blue-dye-safety/)
- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- fronts: [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- technologies: [Compression, decongestive therapy and exercise for lymphoedema](https://onco.cc/technologies/lymphoedema-decongestive-therapy/), [Lymphoedema: catching it early, and the operations for it](https://onco.cc/technologies/lymphoedema-surgery-and-early-detection/), [Measuring lymphoedema: tape, bioimpedance and the quality of life scales](https://onco.cc/technologies/rejuv-measure-lymphoedema/), [Pneumatic compression pumps for lymphoedema (Flexitouch, Lympha Press, Hydroven)](https://onco.cc/technologies/pneumatic-compression-lymphoedema/), [Sentinel lymph node biopsy](https://onco.cc/technologies/sentinel-node/)
- terms: [Lymphoedema after breast cancer treatment](https://onco.cc/terms/breast-cancer-related-lymphoedema/), [Lymphoedema after breast cancer treatment](https://onco.cc/terms/lymphoedema-after-breast-cancer/)
- ideas: [Prospective arm-volume surveillance to catch and reverse lymphoedema early](https://onco.cc/ideas/idea-acc-lymphoedema-prospective-surveillance/), [Replace blanket arm prohibitions after breast cancer with advice that matches the evidence](https://onco.cc/ideas/idea-upgrade-evidence-based-arm-precautions-after-breast-cancer/)

---
JSON: https://onco.cc/api/v1/entities/lymphoedema-risk-reduction-surveillance-and-treatment.json